Evidence map›Paper›PMID 35862760›Full record

ArticleJournal of clinical microbiology2022

Acinetobacter baumannii Genomic Sequence-Based Core Genome Multilocus Sequence Typing Using Ridom SeqSphere+ and Antimicrobial Susceptibility Prediction in ARESdb.

Madiha Fida, Scott A Cunningham, Stephan Beisken, Andreas E Posch, Nicholas Chia, Patricio R Jeraldo, Matthew P Murphy, Nicole M Zinsmaster, Robin Patel, Antibacterial Resistance Leadership Group

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. High-Resolution Genomic Surveillance of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Madiha Fida *Division of Infectious Diseases, Department of Medicine, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.ORCID 0000-0002-3630-0668
Scott A Cunningham *Division of Clinical Microbiology, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.
Stephan BeiskenAres Genetics GmbH, Vienna, Austria.
Andreas E PoschAres Genetics GmbH, Vienna, Austria.
Nicholas ChiaCenter for Individualized Medicine, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.
Patricio R JeraldoCenter for Individualized Medicine, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.ORCID 0000-0003-0282-4217
Matthew P MurphyDivision of Clinical Microbiology, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.
Nicole M ZinsmasterDivision of Clinical Microbiology, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.
Robin PatelDivision of Infectious Diseases, Department of Medicine, Mayo Clinicgrid.66875.3agrid.470142.4grid.66875.3a, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141
Antibacterial Resistance Leadership Group

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

Whole-genome sequencing (WGS) is rapidly replacing traditional typing methods for the investigation of infectious disease outbreaks. Additionally, WGS data are being used to predict phenotypic antimicrobial susceptibility. Acinetobacter baumannii, which is often multidrug-resistant, is a significant culprit in outbreaks in health care settings. A well-characterized collection of A. baumannii was studied using core genome multilocus sequence typing (cgMLST). Seventy-two isolates previously typed by PCR-electrospray ionization mass spectrometry (PCR/ESI-MS) provided by the Antimicrobial Resistance Leadership Group (ARLG) were analyzed using a clinical microbiology laboratory developed workflow for cgMLST with genomic susceptibility prediction performed using the ARESdb platform. Previously performed PCR/ESI-MS correlated with cgMLST using relatedness thresholds of allelic differences of ≤9 and ≤200 allelic differences in 78 and 94% of isolates, respectively. Categorical agreement between genotypic and phenotypic antimicrobial susceptibility across a panel of 11 commonly used drugs was 89%, with minor, major, and very major error rates of 8%, 11%, and 1%, respectively.

Indexed as

Acinetobacter baumanniiAnti-Infective AgentsGenome, BacterialGenomicsHumansMultilocus Sequence TypingAnti-Infective Agentsantimicrobial resistancecgMLSTgenotypic resistancewhole-genome sequencing

Identifiers

PMID35862760
PMCPMC9383114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.